Nigel P Mongan

Dr. Nigel P Mongan

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2016 in Nature
Verified
Journal Article
Closed access
IHIrmgard U. Haussmann
Irmgard U. Haussmann
ZBZsuzsanna Bodi
Zsuzsanna Bodi
ESEugenio Sanchez-Moran
Eugenio Sanchez-Moran
NMNigel P Mongan
Nigel P Mongan
NANathan Archer
Nathan Archer
Matthias SollerMatthias Soller
Matthias Soller

15 May 2017 in New Phytologist
Verified
Journal Article
Open access
PDF file
KRKamil Růžička
Kamil Růžička
MZMi Zhang
Mi Zhang
ACAna Campilho
Ana Campilho
ZBZsuzsanna Bodi
Zsuzsanna Bodi
MKMuhammad Kashif
Muhammad Kashif
RFRupert Fray
Rupert Fray
Summary: N6‐adenosine methylation (m6A) of mRNA is an essential process in most eukaryotes, but its role and the status of factors accompanying this modification are still poorly understood. Using combined methods of genetics, proteomics and RNA biochemistry, we identified a core set of mRNA m6A writer proteins in Arabidopsis thaliana. The components required for m6A in Arabidopsis included MTA, MTB, FIP37, VIRILIZER and the E3 ubiquitin ligase HAKAI. Downregulation of these proteins led to reduced relative m6A levels and shared pleiotropic phenotypes, which included aberrant vascular formation in the root, indicating that correct m6A methylation plays a role in developmental decisions during pattern formation. The conservation of these proteins amongst eukaryotes and the demonstration of a role in writing m6A for the E3 ubiquitin ligase HAKAI is likely to be of considerable relevance beyond the plant sciences.

1 September 2009 in Stem Cells and Development
Verified
Journal Article
Closed access
VKVasundhra Kashyap
Vasundhra Kashyap
NRNaira C. Rezende
Naira C. Rezende
KSKymora B. Scotland
Kymora B. Scotland
SSSebastian M. Shaffer
Sebastian M. Shaffer
JPJenny Persson
Jenny Persson
NMNigel P Mongan
Nigel P Mongan
Coordinated transcription factor networks have emerged as the master regulatory mechanisms of stem cell pluripotency and differentiation. Many stem cell-specific transcription factors, including the pluripotency transcription factors, OCT4, NANOG, and SOX2 function in combinatorial complexes to regulate the expression of loci, which are involved in embryonic stem (ES) cell pluripotency and cellular differentiation. This review will address how these pathways form a reciprocal regulatory circuit whereby the equilibrium between stem cell self-renewal, proliferation, and differentiation is in perpetual balance. We will discuss how distinct epigenetic repressive pathways involving polycomb complexes, DNA methylation, and microRNAs cooperate to reduce transcriptional noise and to prevent stochastic and aberrant induction of differentiation. We will provide a brief overview of how these networks cooperate to modulate differentiation along hematopoietic and neuronal lineages. Finally, we will describe how aberrant functioning of components of the stem cell regulatory network may contribute to malignant transformation of adult stem cells and the establishment of a “cancer stem cell” phenotype and thereby underlie multiple types of human malignancies.

24 October 2017 in Acta Veterinaria Scandinavica
Verified
Journal Article
Open access
PDF file
SSSiobhan Simpson
Siobhan Simpson
MDMark David Dunning
Mark David Dunning
SBSimone de Brot
Simone de Brot
LRLlorenç Grau Roma
Llorenç Grau Roma
NMNigel P Mongan
Nigel P Mongan
CRCatrin Sian Rutland
Catrin Sian Rutland
Osteosarcoma (OSA) is a rare cancer in people. However OSA incidence rates in dogs are 27 times higher than in people. Prognosis in both species is relatively poor, with 5 year OSA survival rates in people not having improved in decades. For dogs, 1 year survival rates are only around ~ 45%. Improved and novel treatment regimens are urgently required to improve survival in both humans and dogs with OSA. Utilising information from genetic studies could assist in this in both species, with the higher incidence rates in dogs contributing to the dog population being a good model of human disease. This review compares the clinical characteristics, gross morphology and histopathology, aetiology, epidemiology, and genetics of canine and human OSA. Finally, the current position of canine OSA genetic research is discussed and areas for additional work within the canine population are identified.

1 August 2013 in The American Journal of Human Genetics
Verified
Journal Article
Open access
DMDaniel J. Moore
Daniel J. Moore
AOAlexandros Onoufriadis
Alexandros Onoufriadis
ASAmelia Shoemark
Amelia Shoemark
MSMichael A. Simpson
Michael A. Simpson
PLPetra I. Zur Lage
Petra I. Zur Lage
HMHannah M. Mitchison
Hannah M. Mitchison
Primary ciliary dyskinesia (PCD) is a ciliopathy characterized by airway disease, infertility, and laterality defects, often caused by dual loss of the inner dynein arms (IDAs) and outer dynein arms (ODAs), which power cilia and flagella beating. Using whole-exome and candidate-gene Sanger resequencing in PCD-affected families afflicted with combined IDA and ODA defects, we found that 6/38 (16%) carried biallelic mutations in the conserved zinc-finger gene BLU (ZMYND10). ZMYND10 mutations conferred dynein-arm loss seen at the ultrastructural and immunofluorescence level and complete cilia immotility, except in hypomorphic p.Val16Gly (c.47T>G) homozygote individuals, whose cilia retained a stiff and slowed beat. In mice, Zmynd10 mRNA is restricted to regions containing motile cilia. In a Drosophila model of PCD, Zmynd10 is exclusively expressed in cells with motile cilia: chordotonal sensory neurons and sperm. In these cells, P-element-mediated gene silencing caused IDA and ODA defects, proprioception deficits, and sterility due to immotile sperm. Drosophila Zmynd10 with an equivalent c.47T>G (p.Val16Gly) missense change rescued mutant male sterility less than the wild-type did. Tagged Drosophila ZMYND10 is localized primarily to the cytoplasm, and human ZMYND10 interacts with LRRC6, another cytoplasmically localized protein altered in PCD. Using a fly model of PCD, we conclude that ZMYND10 is a cytoplasmic protein required for IDA and ODA assembly and that its variants cause ciliary dysmotility and PCD with laterality defects.

11 March 2011 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
EKEric C. Kauffman
Eric C. Kauffman
BRBrian D. Robinson
Brian D. Robinson
MDMartin J. Downes
Martin J. Downes
LPLeagh G. Powell
Leagh G. Powell
MLMing Ming Lee
Ming Ming Lee
NMNigel P Mongan
Nigel P Mongan